Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial

Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial

Abstract Background Cryptosporidium infection and diarrhea (cryptosporidiosis) is a life-threatening infection in persons with HIV and also in children of 6–18 months of age in the developing world. To date, only nitazoxanide is licensed for treatment of cryptosporidiosis, and only in persons after...

Full description

Bibliographic Details
Main Authors: Patrick Nachipo, David Hermann, Gerald Quinnan, Melita A. Gordon, Wesley C. Van Voorhis, Pui-Ying Iroh Tam
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Trials
Subjects:
Cryptosporidium
Diarrhea
HIV
Clofazimine
Lamprene
Immunosuppression
Online Access:http://link.springer.com/article/10.1186/s13063-018-2846-6

Internet

http://link.springer.com/article/10.1186/s13063-018-2846-6

Similar Items